Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026)

Bruker (BRKR) posted Net Income towards Common Stockholders of $3.5 million for Q1 2026, down 76.51% on a QoQ basis from $14.9 million in Q4 2025, and down 79.89% year-over-year from $17.4 million in Q1 2025.

Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Bruker's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $3.5 million for Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 79.89% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.0 million (down 162.81% YoY) and the FY2025 annual result came in at -$22.5 million, down 119.89% from the prior year.
  • Net Income towards Common Stockholders was $3.5 million for Q1 2026 at Bruker, down from $14.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $205.5 million in Q4 2023 and bottomed at -$62.4 million in Q3 2025.
  • A 5-year average of $47.3 million and a median of $49.5 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 110.99% — and 2025, when it sank 252.57%.
  • Bruker's Net Income towards Common Stockholders stood at $97.4 million in 2022, then soared by 110.99% to $205.5 million in 2023, then slumped by 93.33% to $13.7 million in 2024, then rose by 8.76% to $14.9 million in 2025, then sank by 76.51% to $3.5 million in 2026.
  • Business Quant data shows BRKR's Net Income towards Common Stockholders at $3.5 million in Q1 2026, $14.9 million in Q4 2025, and -$62.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Bruker 9.14 Bn 9.14 Bn 379.80 Mn 3.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.50 Mn
Dec 31, 2025 14.90 Mn
Sep 30, 2025 -62.40 Mn
Jun 30, 2025 -6.00 Mn
Mar 31, 2025 17.40 Mn
Dec 31, 2024 13.70 Mn
Sep 30, 2024 40.90 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 50.90 Mn
Dec 31, 2023 205.50 Mn
Sep 30, 2023 88.10 Mn
Jun 30, 2023 57.10 Mn
Mar 31, 2023 76.50 Mn
Dec 31, 2022 97.40 Mn
Sep 30, 2022 88.10 Mn
Jun 30, 2022 49.50 Mn
Mar 31, 2022 61.60 Mn
Dec 31, 2021 75.70 Mn
Sep 30, 2021 87.10 Mn
Jun 30, 2021 57.60 Mn